Harvey R. Herschman

Harvey R. Herschman's AcademicInfluence.com Rankings

Harvey R. Herschman

Biology

#4930

World Rank

#7281

Historical Rank

Molecular Biology

#409

World Rank

#417

Historical Rank

Biochemistry

#547

World Rank

#635

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Harvey R. Herschman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harvey R. Herschman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. (1991) (1765)
Prostaglandin synthase 2. (1996) (1299)
Primary response genes induced by growth factors and tumor promoters. (1991) (1066)
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. (1998) (554)
Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas (1981) (495)
Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. (1992) (477)
The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine N-Methyltransferase* (1996) (473)
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription (2001) (445)
PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* (2000) (422)
Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. (1992) (397)
Molecular Imaging: Looking at Problems, Seeing Solutions (2003) (390)
Target identification using drug affinity responsive target stability (DARTS) (2009) (383)
Transcriptional Activation of the Cyclooxygenase-2 Gene in Endotoxin-treated RAW 264.7 Macrophages* (2000) (364)
Target identification using drug affinity responsive target stability (DARTS). (2009) (348)
Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. (1987) (348)
PRMT 3, a Type I Protein Arginine N-Methyltransferase That Differs from PRMT1 in Its Oligomerization, Subcellular Localization, Substrate Specificity, and Regulation* (1998) (316)
v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) (1995) (316)
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. (2012) (290)
Transcriptional Regulation of Prostaglandin Synthase 2 Gene Expression by Platelet-derived Growth Factor and Serum* (1996) (260)
Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. (1978) (255)
Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. (1994) (255)
Variants of 3T3 cells lacking mitogenic response to epidermal growth factor. (1977) (234)
Quantification of target gene expression by imaging reporter gene expression in living animals (2000) (229)
v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element (1994) (223)
Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. (2001) (212)
The murine neutrophil‐chemoattractant chemokines LIX, KC, and MIP‐2 have distinct induction kinetics, tissue distributions, and tissue‐specific sensitivities to glucocorticoid regulation in endotoxemia (1998) (206)
Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors (2006) (205)
Protein-arginine Methyltransferase I, the Predominant Protein-arginine Methyltransferase in Cells, Interacts with and Is Regulated by Interleukin Enhancer-binding Factor 3* (2000) (190)
The Predominant Protein-arginine Methyltransferase from Saccharomyces cerevisiae(*) (1996) (188)
The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat (1991) (185)
S100 protein is present in cultured human malignant melanomas (1980) (184)
The RGG domain in hnRNP A2 affects subcellular localization. (2000) (181)
Prostaglandin Synthase-1 and Prostaglandin Synthase-2 Are Coupled to Distinct Phospholipases for the Generation of Prostaglandin D2 in Activated Mast Cells* (1997) (175)
Analysis of the Secretory Phospholipase A2 That Mediates Prostaglandin Production in Mast Cells* (1997) (173)
Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. (1993) (171)
Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. (1991) (169)
Synaptotagmin IV is an immediate early gene induced by depolarization in PC12 cells and in brain. (1995) (159)
Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. (1994) (156)
Metallothionein mRNA induction in HeLa cells in response to zinc or dexamethasone is a primary induction response (1980) (155)
Unusual Sites of Arginine Methylation in Poly(A)-binding Protein II and in Vitro Methylation by Protein Arginine Methyltransferases PRMT1 and PRMT3* (1999) (155)
S100 PROTEIN: A MARKER FOR HUMAN MALIGNANT MELANOMAS? (1981) (153)
Specific radiolabeling of a cell surface receptor for epidermal growth factor. (1977) (153)
Purification and characterization of colicin E2 and colicin E3. (1967) (146)
Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. (1995) (142)
Nucleotide sequence of a cDNA encoding TIS11, a message induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. (1989) (141)
Regulation of prostaglandin synthase-1 and prostaglandin synthase-2 (1994) (140)
Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells (2010) (139)
Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways (2015) (138)
The influence of innate and pre‐existing immunity on adenovirus therapy (2009) (136)
Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche (2020) (134)
Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic (1980) (128)
Transcriptional Regulation of the Cyclooxygenase-2 Gene in Activated Mast Cells* (2000) (128)
In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. (1994) (126)
Dexamethasone stimulation of metallothionein synthesis in HeLa cell cultures. (1979) (125)
Comparative Study of the Events Associated with Colicin Induction (1967) (123)
DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo (2004) (121)
Protein binding and signaling properties of RIN1 suggest a unique effector function. (1997) (120)
Detection of S‐100 protein as an aid to the identification of melanocytic tumors (1982) (118)
Subcellular fractionation of cultured glial cells. (1971) (117)
Transcellular Prostaglandin Production following Mast Cell Activation Is Mediated by Proximal Secretory Phospholipase A and Distal Prostaglandin Synthase 1 (*) (1996) (117)
Induction of c‐fos and TIS genes in cultured rat astrocytes by neurotransmitters (1989) (116)
Molecular imaging in the development of cancer therapeutics. (2006) (113)
MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart (2010) (107)
Deficits in memory and motor performance in synaptotagmin IV mutant mice. (2000) (106)
Micro-PET imaging and small animal models of disease. (2003) (105)
KID-1, a Protein Kinase Induced by Depolarization in Brain* (1998) (105)
PET imaging of transgene expression (2000) (105)
Synaptotagmin IV determines the linear Ca2+ dependence of vesicle fusion at auditory ribbon synapses (2010) (105)
Seeing is believing: Non‐invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography (2000) (103)
APPEARANCE OF A BRAIN‐SPECIFIC ANTIGEN (S‐100 PROTEIN) IN THE DEVELOPING RAT BRAIN 1 (1971) (100)
Glucocorticoid-attenuated Response Genes Encode Intercellular Mediators, Including a New C-X-C Chemokine (*) (1995) (98)
Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography (2005) (97)
Initiation of 3T3 fibroblast cell division by epidermal growth factor (1975) (97)
Induction of transiently expressed genes in PC-12 pheochromocytoma cells. (1987) (97)
TAB-1 Modulates Intracellular Localization of p38 MAP Kinase and Downstream Signaling* (2006) (93)
Extracellular signals, transcriptional responses and cellular specificity. (1989) (92)
Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. (1993) (89)
Micro–Positron Emission Tomography Imaging of Cardiac Gene Expression in Rats Using Bicistronic Adenoviral Vector-Mediated Gene Delivery (2004) (88)
Deletion of Prostaglandin E2 Synthesizing Enzymes in Brain Endothelial Cells Attenuates Inflammatory Fever (2014) (88)
Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. (1999) (85)
Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism (2009) (85)
Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs (2008) (83)
Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. (2002) (83)
Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development (2012) (83)
Inflammation, reproduction, cancer and all that…. The regulation and role of the inducible prostaglandin synthase (1995) (82)
Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. (2002) (82)
Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells. (1995) (81)
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia (2010) (81)
Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress (2012) (79)
Occult melanoma in lymph nodes detected by antiserum to S‐100 protein (1984) (79)
The zebrafish genome contains two inducible, functional cyclooxygenase-2 genes. (2007) (77)
Adrenergic, cholinergic, and inactive human neuroblastoma cell lines with the action-potential Na+ ionophore. (1977) (77)
Metal-dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter (1987) (76)
Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells (1989) (76)
Requirement for deoxycytidine kinase in T and B lymphocyte development (2009) (75)
Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. (2002) (74)
Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. (2006) (74)
The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains. (1996) (74)
Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. (2010) (71)
TIS gene expression in cultured rat astrocytes: Induction by mitogens and stellation agents (1989) (68)
Function and regulation of prostaglandin synthase 2. (1999) (68)
Rat metallothionein-1 structural gene and three pseudogenes, one of which contains 5'-regulatory sequences (1986) (67)
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis (2014) (64)
Nerve growth factor‐mediated increases in protein methylation occur predominantly at type I arginine methylation sites and involve protein arginine methyltransferase 1 (2002) (64)
Biochemically differentiated clonal human glial cells in tissue culture. (1970) (64)
Altered hippocampal short‐term plasticity and associative memory in synaptotagmin IV (−/−) mice (2004) (64)
PET reporter genes for noninvasive imaging of gene therapy, cell tracking and transgenic analysis. (2004) (63)
Primary induction of metallothionein by dexamethasone in culture rat hepatocytes. (1980) (62)
The Salt‐Inducible Kinase, SIK, Is Induced by Depolarization in Brain (2000) (62)
[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity (2016) (62)
TGF‐beta1 inhibits both endotoxin‐induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene in murine macrophages (1994) (61)
The Urokinase Plasminogen Activator Receptor (UPAR) Is Preferentially Induced by Nerve Growth Factor in PC12 Pheochromocytoma Cells and Is Required for NGF-Driven Differentiation (2000) (61)
Noninvasive imaging of reporter gene expression in living subjects. (2004) (61)
A corrected sequence for the predicted protein from the mitogen-inducible TIS11 primary response gene. (1991) (61)
Synthesis of 8-[18F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography ☆ (2000) (60)
Two synaptotagmin genes, Syt1 and Syt4, are differentially regulated in adult brain and during postnatal development following kainic acid-induced seizures. (1996) (59)
Genes preferentially induced by depolarization after concussive brain injury: effects of age and injury severity. (2002) (59)
Bone Morphogenetic Protein 2 Induces Cyclo‐oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo (2002) (58)
Characterization of the metallothioneins induced in HeLa cells by dexamethasone and zinc. (2005) (57)
Tis gene expression in cultured rat astrocytes: Multiple pathways of induction by mitogens (1989) (57)
“Macrophage” nitric oxide synthase is a glucocorticoid‐inhibitable primary response gene in 3T3 cells (1993) (56)
LC-MS/MS Confirms That COX-1 Drives Vascular Prostacyclin Whilst Gene Expression Pattern Reveals Non-Vascular Sites of COX-2 Expression (2013) (56)
Function and regulation of prostaglandin synthase-2. (1997) (56)
Induction of metallothionein mRNA in HeLa cells by dexamethasone and by heavy metals. (1981) (55)
Regulation of metallothionein synthesis in HeLa cells by heavy metals and glucocorticoids (1981) (55)
Neural antigens of morphologically differentiated neuroblastoma cells (1974) (55)
Levels of metallothionein messenger RNA in foetal, neonatal and maternal rat liver. (1983) (54)
Heavy metals induce expression of the TPA‐inducible sequence (TIS) genes (1991) (54)
Tumor promoter modulation of epidermal growth factor‐ and nerve growth factor‐induced adhesion and growth factor binding of PC‐12 pheochromocytoma cells (1980) (54)
Bone Morphogenetic Protein 2 Induces Cyclo‐oxygenase 2 in Osteoblasts via a Cbfa1 Binding Site: Role in Effects of Bone Morphogenetic Protein 2 In Vitro and In Vivo (2005) (54)
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography (2009) (54)
Conditional knockout mouse for tissue‐specific disruption of the cyclooxygenase‐2 (Cox‐2) gene (2006) (53)
Molecular cloning of the rat metallothionein 1 (MT-1) mRNA sequence. (1983) (53)
Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3',5'-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. (1997) (52)
Polypeptide growth factors and the CNS (1986) (52)
Nurr1 mRNA expression in neonatal and adult rat brain following kainic acid-induced seizure activity. (1998) (52)
Functional and biochemical analysis of the C2 domains of synaptotagmin IV. (1999) (52)
A tumor agnostic therapeutic strategy for Hexokinase 1 Null/Hexokinase 2 positive cancers. (2019) (52)
Tumor promoter-inducible genes are differentially expressed in the developing mouse (1988) (52)
Induction of tumor promotor-inducible genes in murine 3T3 cell lines and tetradecanoyl phorbol acetate-nonproliferative 3T3 variants can occur through protein kinase C-dependent and -independent pathways (1989) (52)
Stimulation of Hair Growth by Small Molecules that Activate Autophagy. (2019) (51)
Modulation of cell-surface antigens of a murine neuroblastoma. (1974) (51)
Regulation of the rat metallothionein-I gene by sodium butyrate. (1986) (51)
Variants of 3T3 cells lacking mitogenic response to the tumor promoter tetradecanoyl‐phorbol‐acetate (1981) (51)
Synthesis, Degradation, and Subcellular Localization of Synaptotagmin IV, a Neuronal Immediate Early Gene Product (1999) (51)
Adenovirus tumor targeting and hepatic untargeting by a coxsackie/adenovirus receptor ectodomain anti-carcinoembryonic antigen bispecific adapter. (2007) (51)
Induction of metallothionein in HeLa cells by dexamethasone and zinc. (1981) (50)
Imaging Cyclooxygenase-2 (Cox-2) Gene Expression in Living Animals with a Luciferase Knock-in Reporter Gene (2006) (50)
Cholera toxin stimulates division of 3T3 cells (1979) (50)
Transforming growth factor β1 augments mitogen‐induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in swiss 3T3 cells and in murine embryo fibroblasts (1994) (50)
Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. (2011) (48)
Metallothionein in a human cell line: the response of HeLa cells to cadmium and zinc. (1979) (47)
Two inducible, functional cyclooxygenase‐2 genes are present in the rainbow trout genome (2007) (47)
Surprisal analysis characterizes the free energy time course of cancer cells undergoing epithelial-to-mesenchymal transition (2014) (47)
Differential induction of primary-response (TIS) genes in PC12 pheochromocytoma cells and the unresponsive variant PC12nnr5. (1991) (47)
The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression. (1989) (45)
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. (2002) (44)
Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer (2020) (44)
Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors (2016) (44)
Sequence similarities of a subgroup of CXC chemokines related to murine LIX: implications for the interpretation of evolutionary relationships among chemokines (1997) (44)
Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3 (1994) (43)
Metal-dependent binding of a nuclear factor to the rat metallothionein-I promoter. (1990) (43)
Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. (2019) (43)
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways (2017) (42)
Characterization of TIS7, a gene induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate. (1989) (42)
COX-2 Induction during Murine Gammaherpesvirus 68 Infection Leads to Enhancement of Viral Gene Expression (2003) (42)
The Drosophila TIS11 homologue encodes a developmentally controlled gene. (1994) (42)
Structure-guided Engineering of Human Thymidine Kinase 2 as a Positron Emission Tomography Reporter Gene for Enhanced Phosphorylation of Non-natural Thymidine Analog Reporter Probe* (2011) (41)
Cloning and characterization of the human granulocyte chemotactic protein-2 gene. (1997) (41)
Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse. (1993) (41)
Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. (2003) (40)
Epidermal growth factor induces tyrosine hydroxylase in a clonal pheochromocytoma cell line, PC-G2 (1980) (39)
Spectrally resolved bioluminescence tomography with the third-order simplified spherical harmonics approximation (2009) (39)
Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes. (1981) (39)
Glucocorticoid hormone receptor mediated induction of metallothionein synthesis in HeLa cells (1980) (39)
Toxicity of ligand and antibody‐directed ricin A‐chain conjugates recognizing the epidermal growth factor receptor (1987) (39)
Production of a nervous-system-specific protein (14-3-2) by human neuroblastoma cells in culture. (1973) (38)
Identification of genes preferentially induced by nerve growth factor versus epidermal growth factor in PC12 pheochromocytoma cells by means of representational difference analysis (1997) (38)
Metallothionein synthesis in foetal, neonatal and maternal rat liver. (1983) (38)
COX‐2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors (2014) (37)
The tis genes, primary response genes induced by growth factors and tumor promoters in 3T3 cells. (1994) (37)
The yeast homologue YTIS11, of the mammalian TIS11 gene family is a non-essential, glucose repressible gene. (1995) (37)
Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography. (2005) (37)
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication (2014) (37)
Detection of cytoplasmic S-100 protein in primary and metastatic intraocular melanomas. (1983) (36)
Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines. (2007) (36)
Effect of Rec− Mutations on the Activity of Colicinogenic Factors (1967) (36)
Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin (1982) (35)
In Vivo Mouse Bioluminescence Tomography with Radionuclide-Based Imaging Validation (2010) (34)
Identification of multiple cis‐acting elements mediating the induction of prostaglandin G/H synthase‐2 by phorbol ester in murine osteoblastic cells (2000) (34)
Synthesis and degradation of a brain-specific protein (S100 protein) by clonal cultured human glial cells. (1971) (34)
Reduced anxiety and depression-like behavior in synaptotagmin IV (−/−) mice (2004) (34)
Experimental bioluminescence tomography with fully parallel radiative-transfer-based reconstruction framework. (2009) (33)
Cell-type-specific roles for COX-2 in UVB-induced skin cancer. (2014) (33)
TIS10, a mitogen-inducible glucocorticoid-inhibited gene that encodes a second prostaglandin synthase/cyclooxygenase enzyme. (1993) (32)
Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors. (2009) (32)
Synaptotagmin IV overexpression inhibits depolarization‐induced exocytosis in PC12 cells (2004) (31)
Metallothionein accumulation in response to cadmium in a clonal rat liver cell line. (1978) (31)
Singing, but not seizure, induces synaptotagmin IV in zebra finch song circuit nuclei. (2006) (31)
Ultraviolet irradiation transforms C3H10T1/2 cells to a unique, suppressible phenotype. (1986) (31)
Serologic specificities of brain subcellular organelles. I. Antisera to synaptosomal fractions. (1972) (30)
Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. (1999) (30)
The mouse macrophage activation‐associated marker protein, p71/73, is an inducible prostaglandin endoperoxide synthase (cyclooxygenase) (1993) (30)
Analysis of phorbol ester receptors in phorbol ester unresponsive 3T3 cell variants. (1981) (29)
Butyrate-induced changes in nuclease sensitivity of chromatin cannot be correlated with transcriptional activation (1987) (29)
Expression of the urokinase plasminogen activator receptor is transiently required during “priming” of PC12 cells in nerve growth factor‐directed cellular differentiation (2001) (28)
Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo (2015) (28)
Transforming Growth Factor-β1 Regulation of Prostaglandin G/H Synthase-2 Expression in Osteoblastic MC3T3-E1 Cells. (1997) (28)
Glucocorticoid induction of tyrosine hydroxylase in a continous cell line of rat pheochromocytoma (1978) (28)
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1-HK2+ Multiple Myeloma. (2019) (28)
Absence of Myeloid COX-2 Attenuates Acute Inflammation but Does Not Influence Development of Atherosclerosis in Apolipoprotein E Null Mice (2010) (28)
Cloning and genomic localization of the murine LPS-induced CXC chemokine (LIX) gene, Scyb5 (2002) (27)
Seizure activity induces PIM‐1 expression in brain (1998) (27)
PGE2/EP4 Signaling Controls the Transfer of the Mammary Stem Cell State by Lipid Rafts in Extracellular Vesicles (2017) (27)
COX-2 expression and function in the hyperalgesic response to paw inflammation in mice. (2008) (27)
Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway (2018) (26)
Parathyroid Hormone Induction of Cyclooxygenase-2 in Murine Osteoblasts: Role of the Calcium-Calcineurin-NFAT Pathway (2009) (26)
Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. (2010) (26)
Noninvasive imaging of transcriptionally restricted transgene expression following intratumoral injection of an adenovirus in which the COX-2 promoter drives a reporter gene. (2004) (26)
Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. (2013) (25)
The Spatiotemporal Role of COX-2 in Osteogenic and Chondrogenic Differentiation of Periosteum-Derived Mesenchymal Progenitors in Fracture Repair (2014) (25)
Epidermal growth factor-nonresponsive 3T3 variants do not contain epidermal growth factor receptor-related antigens or mRNA. (1986) (25)
EP4 Antagonist‐Elicited Extracellular Vesicles from Mesenchymal Stem Cells Rescue Cognition/Learning Deficiencies by Restoring Brain Cellular Functions (2019) (24)
Protein phosphorylation in a tetradecanoyl phorbol acetate-nonproliferative variant of 3T3 cells (1985) (24)
Primary response gene expression in renal hypertrophy and hyperplasia: evidence for different growth initiation processes. (1991) (24)
Glucose uptake and ornithine decarboxylase activity in tetradecanoyl phorbol acetate non‐proliferative variants (1983) (24)
Nerve growth factor-mediated induction of tyrosine hydroxylase in a clonal pheochromocytoma cell line. (1978) (23)
Feedback regulation of cyclooxygenase-2 transcription ex vivo and in vivo. (2009) (23)
Mitogenic response to epidermal growth factor: relationship to number, affinity, and down-regulation of EGF receptors in three murine embryo cell lines. (1978) (23)
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers (2018) (23)
Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ mice (2014) (22)
Nervous System-Specific Proteins in Cultured Neural Cells (1973) (22)
Targeted Deletion and Lipidomic Analysis Identify Epithelial Cell COX-2 as a Major Driver of Chemically Induced Skin Cancer (2014) (22)
Early responses of PC‐12 cells to NGF and EGF: Effect of K252a and 5′‐methylthioadenosine on gene expression and membrane protein methylation (1993) (22)
Recent progress in the cellular and molecular biology of prostaglandin synthesis. (1998) (22)
Exosomal 2′,3′‐CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis/neuritogenesis and contributes to rescue of cognition/learning deficiencies of damaged brain (2020) (21)
Serologic comparisons of the carbonic anhydrases of primate erythrocytes. (1970) (21)
Noninvasive of adenovirus tumor retargeting in living subjects by a soluble adenovirus receptor-epidermal growth factor (sCAR-EGF) fusion protein. (2004) (21)
7 – The EGF Receptor (1985) (21)
Platelets Contain Tissue Factor Pathway Inhibitor-2 Derived from Megakaryocytes and Inhibits Fibrinolysis* (2014) (20)
Neuronal and nonneuronal COX‐2 expression confers neurotoxic and neuroprotective phenotypes in response to excitotoxin challenge (2014) (19)
12-O-tetradecanoylphorbol-13-acetate stimulates release of arachidonic acid, prostaglandin E2 and prostaglandin F2 alpha from TPA nonproliferative variants of 3T3 cells. (1983) (19)
Colony size, cell density and nature of the tumor promoter are critical variables in expression of a transformed phenotype (focus formation) in co-cultures of UV-TDTx and C3H10T1/2 cells. (1987) (19)
Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients (2021) (19)
Preferential primary‐response gene expression in promotion‐resistant versus promotion‐sensitive JB6 cells (1994) (19)
Disuccinimidyl suberate cross-linked ricin does not inhibit cell-free protein synthesis. (1982) (19)
A Method to Rapidly and Accurately Compare the Relative Efficacies of Non-invasive Imaging Reporter Genes in a Mouse Model and its Application to Luciferase Reporters (2012) (19)
Subcellular structures involved in internalization and degradation of epidermal growth factor. (1981) (18)
Transgenic mouse for conditional, tissue‐specific Cox‐2 overexpression (2006) (18)
The MAPK pathway is required for depolarization‐induced “promiscuous” immediate‐early gene expression but not for depolarization‐restricted immediate‐early gene expression in neurons (2008) (18)
Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma. (1988) (18)
Expression of depolarization‐induced immediate early gene proteins in PC12 cells (2003) (18)
Neurochemical properties of cell lines fromN-ethyl-N-nitrosourea induced rat tumors (1977) (18)
Radiochemistry on electrodes: Synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor (2017) (18)
Differential Effects of Murine and Human Factor X on Adenovirus Transduction via Cell-surface Heparan Sulfate* (2011) (18)
3T3 variants lacking receptors for epidermal growth factor are susceptible to transformation by Kirsten sarcoma virus (1978) (17)
Historical Aspects of COX-2: Cloning and Characterization of the cDNA, Protein and Gene (2002) (17)
Glucocorticoid-attenuated response genes induced in the lung during endotoxemia. (2002) (17)
Hexokinase 2 Is Targetable for HK1-Negative, HK2-Positive Tumors from a Wide Variety of Tissues of Origin (2018) (17)
S-100 protein in amelanotic melanoma. A convenient immunocytochemical approach compared to electron microscopy. (1986) (17)
Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging (2008) (17)
Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin Paradox (2019) (17)
A 12-O-tetradecanoylphorbol-13-acetate (TPA)-nonproliferative variant of 3T3 cells is resistant to TPA-enhanced gene amplification (1985) (17)
Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. (2010) (17)
Culture of Neural Tissue and Cells (1974) (17)
MAPKAP kinase‐2 is a primary response gene induced by depolarization in PC12 cells and in brain (2004) (16)
4 – Primary Response Gene Expression in the Nervous System (1993) (16)
Identification of inflammatory mediators by screening for glucocorticoid-attenuated response genes. (1997) (16)
The regulation and role of TIS10 prostaglandin synthase-2. (1995) (16)
Conditional Bicistronic Cre Reporter Line Expressing Both Firefly Luciferase and β-galactosidase (2010) (16)
PGE2/EP4 antagonism enhances tumor chemosensitivity by inducing extracellular vesicle‐mediated clearance of cancer stem cells (2018) (15)
Repetitive, noninvasive imaging of cyclooxygenase-2 gene expression in living mice. (2003) (15)
Targeted identification of glucocorticoid-attenuated response genes: in vitro and in vivo models. (2004) (15)
Alternative inducers of the rat metallothionein I gene cause distinct changes in chromatin structure in the 5' region of the gene (1986) (15)
S-100 Protein Synthesis by Isolated Polyribosomes from Rat Brain (1972) (14)
Non‐invasive imaging of reporter genes (2002) (14)
S‐100Protein: A Marker for Melanocytic Tumors a (1983) (14)
Tumorigenic methylcholanthrene transformants of C3H/10T1/2 cells have a common nucleotide alteration in the c-Ki-ras gene. (1989) (13)
A phorbol ester‐nonproliferative variant of Swiss 3T3 cells is deficient in Na+ K+ Cl− cotransport activity (1988) (13)
Epidermal growth factor induced membrane changes in 3T3 cells (1978) (13)
Searching for Depolarization-Induced Genes that Modulate Synaptic Plasticity and Neurotrophin-Induced Genes that Mediate Neuronal Differentiation (2000) (13)
Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease. (2010) (13)
Regulation and Function of Prostaglandin Synthase 2/Cyclooxygenase II (2004) (13)
TGF-beta 1 augments expression of the TIS10/prostaglandin synthase-2 gene in intestinal epithelial cells. (1994) (13)
Positron emission tomography imaging of DMBA/TPA mouse skin multi‐step tumorigenesis (2010) (13)
Synaptotagmin IV (2001) (13)
Development and Application of FASA, a Model for Quantifying Fatty Acid Metabolism Using Stable Isotope Labeling (2018) (12)
rTLE3, a Newly Identified Transducin‐Like Enhancer of Split, Is Induced by Depolarization in Brain (2000) (11)
An epidermal growth factor‐ricin a chain (EGF‐RTA)‐resistant mutant and an epidermal growth factor‐Pseudomonas endotoxin (EGF‐PE)‐resistant mutant have distinct phenotypes (1989) (11)
Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells. (1997) (11)
The role of binding ligand in toxic hybrid proteins: a comparison of EGF-ricin, EGF-ricin A-chain, and ricin. (1984) (11)
NID67, a small putative membrane protein, is preferentially induced by NGF in PC12 pheochromocytoma cells (2001) (11)
HeLa cell mutants resistant to epidermal growth factor ricin A‐chain conjugate (1989) (10)
Toxic ligand conjugates as tools in the study of receptor‐ligand interactions (1982) (10)
Application of a Rapid, Simple, and Accurate Adenovirus-Based Method to Compare PET Reporter Gene/PET Reporter Probe Systems (2013) (10)
The Human Synaptotagmin IV Gene Defines an Evolutionary Break Point between Syntenic Mouse and Human Chromosome Regions but Retains Ligand Inducibility and Tissue Specificity* (2000) (10)
Cox‐2 gene expression in chemically induced skin papillomas cannot predict subsequent tumor fate (2010) (10)
Reactivity of neoplastic cells of hairy cell leukemia with antisera to S-100 protein. (1987) (10)
Rat metallothionein multigene family. (1987) (10)
Historical Aspects of COX-2 (2003) (10)
S-100 protein: a marker for melanocytic tumors. (1983) (9)
A microfluidic platform for sequential ligand labeling and cell binding analysis (2007) (9)
Clonal variations in murine neuroblastoma. Morphologic and antigenic differentiation. (1975) (9)
Diesel Exhaust Particle Extracts and Associated Polycyclic Aromatic Hydrocarbons Inhibit Cox-2-dependent Prostaglandin Synthesis in Murine Macrophages and Fibroblasts* (2002) (9)
Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer (2020) (9)
Is epidermal growth factor a modulator of nervous system function? (1983) (8)
Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference (2014) (8)
Monitoring Gene Therapy by Positron Emission Tomography (2003) (7)
Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin (2020) (7)
Gastrin-releasing peptide-induced expression of prostaglandin synthase-2 in Swiss 3T3 cells. (1997) (7)
3T3 variants unable to bind epidermal growth factor cannot complement in co-culture. (1984) (7)
Hepatic Ischemia and Reperfusion Injury in the Absence of Myeloid Cell-Derived COX-2 in Mice (2014) (7)
Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation (2021) (6)
Mitogen‐specific nonresponsive mutants and the initiation of cellular proliferation (1987) (6)
A reporter mouse for optical imaging of inflammation in mdx muscles (2015) (6)
Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells (2007) (6)
Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair (2022) (6)
Dominant and recessive mitogen‐nonproliferative variants of 3T3 cells (1985) (5)
Zinc and copper in milk and tissues of nursing lethal milk mutant mice. (1987) (5)
Teleocidin is not mitogenic for 12-O-tetradecanoylphorbol-13-acetate non-proliferative variants of 3T3 cells. (1983) (5)
Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice. (2014) (5)
Apolipoprotein A-I mimetics mitigate intestinal inflammation in a COX 2-dependent inflammatory disease model (2019) (5)
Toxic Conjugates of Epidermal Growth Factor and Asialofetuin (1984) (5)
Prostacyclin mediates endothelial COX-2-dependent neuroprotective effects during excitotoxic brain injury (2014) (5)
Coordinate regulation of the inducible forms of prostaglandin synthase and nitric oxide synthase in fibroblasts and macrophages. (1997) (4)
Identification and characterization of a brain-specific antigen enriched in neonatal brain. I. Developmental, regional distribution and molecular weight studies (1978) (3)
Identification and characterization of a brain-specific antigen enriched in neonatal brain. II. Antigenic stability, species cross-reactivity and tumor cell association (1980) (3)
A continuum of transformed phenotypes in C3H/10T1/2 derivatives. (1988) (3)
Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002. (2005) (3)
Instability of a dinucleotide repeat in the 3′‐untranslated region (UTR) of the microsomal prostaglandin E synthase‐1 (mPGES‐1) gene in microsatellite instability‐high (MSI‐H) colorectal carcinoma (2015) (3)
Regulation of COX-2 Expression in Fibroblasts, Osteoblasts, Mast Cells, and Macrophages (2001) (3)
Interaction of epidermal growth factor with initiators and complete carcinogens in the C3H10T1/2 cell culture System (1985) (3)
Metallothionein synthesis and mRNA levels in cultured hepatocytes from lethal milk mutant mice. (1987) (3)
Molecular imaging: A view from the inside (2004) (3)
Synthesis and degradation of hepatic metallothionein in mice differing in susceptibility to cadmium mortality (1983) (3)
Mitogenic effects of murine serum and fibroblast growth factor on EGF nonproliferative variants of 3T3. (1979) (3)
Mitogens for murine embryo cell lines. (1978) (3)
Isolation of mitogen-specific nonproliferative variant cell lines. (1987) (2)
Abstract 18520: Novel Tissue-specific Cyclooxygenase-1 Knockout Mice Demonstrate a Dominant Role for Endothelial Cyclooxygenase-1 in Prostacyclin Production (2017) (2)
Hepatic metallothionein synthesis in neonatal mottled-brindled mutant mice (1983) (2)
A reassessment of methylcholanthrene transformation in the C3H10T1/2 cell culture system. (1990) (2)
Localization of murine macrophage inducible nitric oxide synthase to mouse chromosome 11. (1994) (2)
S-100 protein accumulation in developing animals and cell cultures. (1971) (1)
Comparison of the Efficacy and Sensitivity of Alternative PET Reporter Gene/PET Reporter Probe Systems That Minimize Biological Variables. (2020) (1)
Resolving an underrepresented circulating tumor cell population in lung cancer enabled by Hexokinase 2 analysis (2020) (1)
Epidermal Growth Factor (2012) (1)
Antisense Oligonucleotide Induces Synthetic Lethality in HK 1-HK 2 + Multiple Myeloma (2019) (1)
Assessment of the expression of prostaglandin synthase-2 in Swiss 3T3 fibroblasts. (1999) (1)
CULTURE OF NEURAL TISSUE AND CELLS IN RESEARCH METHODS IN NEUROCHEMISTRY. VOL. II. (1972) (1)
MORPHOLOGIC AND FUNCTIONAL CHARACTERISTICS OF A PERMANENT CELL LINE DERIVED FROM A CEREBELLAR HEMANGIOBLASTOMA (1980) (1)
Induction of metallothionein by zinc in lethal milk mutant mice (1982) (1)
B Cell Activating Factor and c-Myc Regulate the Progression of Chronic Lymphocytic Leukemia. (2009) (1)
Targeted Identification of Glucocorticoid-attenuated Response Genes (2012) (1)
Abstract 18556: Production of High Levels of PGI-M in the Kidney and Bladder Explains the Renal Origin of Urinary Markers of Prostacyclin (2017) (1)
Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer (2020) (1)
DEVELOPMENT OF HEPATIC ISCHEMIA AND REPERFUSION INJURY IS INDEPENDENT OF MYELOID CELL-DERIVED COX-2: 879 (2010) (0)
Transiently Induced Sequences as Potential Mediators of Cellular Proliferation and Differentiation (1988) (0)
Hair regeneration by small molecules that activate autophagy (2018) (0)
Abstract 5571: Adiponectin Improves Angiogenic Repair of Ischemic Muscle through a COX-2 Dependent Mechanism Involving Calreticulin (2008) (0)
Differential utilization of arachidonic acid in cyclooxygenases 1 and 2 (2000) (0)
Paradoxical decrease in norepinephrine content of adult mouse spleen and heart after neonatal nerve growth factor treatment. (1975) (0)
Preparation of 18F-labeled thymidine analogs using click chemistry (2006) (0)
The N terminus is one (2001) (0)
Current BER Scientists: Principal Investigators (2001) (0)
Molecular Imaging of Cancer Gene Therapy (2005) (0)
Abstract B37: Targeting the energy generation triangle to achieve synthetic lethality for treatment of hepatocellular carcinoma (2017) (0)
An alternative p38 activation pathway by TAB1 mediates different downstream effects in cardiac myocytes from MKK3 (2004) (0)
Title Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography (2013) (0)
Tumor glucose utilization predicts response to epidermal growth factor receptor kinase inhibitors (2006) (0)
Purification and Characterization of Colicin E, and Colicin E,* (2003) (0)
Detection andquantification ofS-100 protein inocular tissues andfluids frompatients withintraocular (1988) (0)
New Mouse Model of Crohn's Disease (2010) (0)
Alternative Inducers oftheRatMetallothionein IGeneCause Distinct Changes inChromatin Structure inthe 5'Region oftheGene (1986) (0)
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers (2018) (0)
Understanding the cardiovascular effects of low dose aspirin by using a platelet COX-1-/- mouse model (2018) (0)
Novel Anti-inflammatory Functions For Endothelial and Myeloid Cyclooxygenase-2 in a 1 New Mouse Model of Crohn ’ s Disease 2 3 (2010) (0)
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways (2017) (0)
S-100 PROTEIN SYNTHESIS BY ISOLATED RAT BRAIN POLYRIBOSOMES. (1972) (0)
Tissue fibroblasts are a critical source of prostacyclin and anti-thrombotic protection (2022) (0)
Cox2 reporter gene expression and prostacylin mass spectrometry confirm vascular COX‐1 dominance for prostacyclin production (2013) (0)
A reporter mouse for optical imaging of inflammation in mdx muscles (2015) (0)
Electrochemical radiolabeling of COX-2 inhibitors: potential PET agents for imaging of inflammation. (2015) (0)
Endotoxin induction of luciferase activity in mice transgenic for a COX-2 promoter-luciferase reporter construct (1999) (0)
Mitogen specific nonproliferative variants of swiss 3t3 cells (1988) (0)
Molecular imaging biomarkers to predict resistance to nucleoside analogs in cancer (2008) (0)
Identification of the molecular pathways that drive constitutive renal COX‐2 expression: implications for novel COX‐2‐targetted therapies that spare the cardiovascular system (837.9) (2014) (0)
Selection and characterization of mitogen-specific non-proliferative 3T3 variant cell lines (1983) (0)
Mitogen induced messages in mouse 3t3 cells (1987) (0)
Development of novel Sjogren's Syndrome susceptible mouse lines expressing floxed COX-2 within the major Aec2 disease susceptibility region in chromosome 1 (P4016) (2013) (0)
Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche (2020) (0)
A spotlight from prostate cancer. (2012) (0)
resistant to TPA-enhanced gene amplification. (TPA)-nonproliferative variant of 3T3 cells is A 12-O-tetradecanoylphorbol-13-acetate (2013) (0)
Suppression and Expression of the Transformed Phenotype in Two-Stage C3H10T1/2 Transformants (2020) (0)
Transient induction of gene expression in the nervous system in response to extracellular signals. (1990) (0)
Open Inspection of CBW. (1970) (0)
Developmental Differences in Gene Expression after Fluid Percussion Brain Injury in Rats (1999) (0)
Cre-based deletion of COX-2 within B cells in vitro: steps toward specific nanoparticle-driven COX-2 inactivation in vivo. (P4044) (2013) (0)
Growth factors. (1980) (0)
Effect ofRec-Mutations on theActivity of Colicinogenic Factors (1967) (0)
Nerve growth factor-mediated induction of tyrosine hydroxylase in a clonal pheochromocytoma cell line ( glucocorticoids / adrenal medulla / adrenergic pathway / sympathetic nervous system / tyrosine 3-monooxygenase ) (0)
Tumorigenic methylcholanthrene transformants of C 3 H / 10 T / 2 cells have a common nucleotide alteration in the cKi-ras gene ( malignant transformation / carcinogenesis / ras genes / cell culture ) (0)
In situ click chemistry approach for the identification of carbonic anhydrase II and cyclooxygenase-2 PET imaging agents (2006) (0)
Molecular cloning of a neuroendocrine specific primary response gene with sequence homology to synaptotagmin (1994) (0)
New neural cell lines derived from experimentally induced rat tumors and from human neuroblastomas. (1978) (0)
Remembering Sanjiv (Sam) Gambhir, MD, PhD (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Harvey R. Herschman?

Harvey R. Herschman is affiliated with the following schools:

Harvey R. Herschman's Academic­Influence.com Rankings

Why Is Harvey R. Herschman Influential?

Harvey R. Herschman's Published Works

Published Works

What Schools Are Affiliated With Harvey R. Herschman?

Harvey R. Herschman's AcademicInfluence.com Rankings